Our results add further strength to the existent recommendations to use ACE inhibitors in patients with congestive heart failure, diabetes mellitus, and renal disease, since these patients are at higher risk for either contracting pneumonia or dying from pneumonia when they do contract it. Here, ACE is linked to congestive heart failure.